Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk.

Corre J, Montes L, Martin E, Perrot A, Caillot D, Leleu X, Belhadj K, Facon T, Hulin C, Mohty M, Fontan J, Macro M, Brechignac S, Jaccard A, Stoppa AM, Orsini-Piocelle F, Adiko D, Voillat L, Keddar F, Barry M, Demarquette H, Certain MN, Plantier I, Roussel M, Hébraud B, Filleron T, Attal M, Avet-Loiseau H.

Haematologica. 2019 Dec 19. pii: haematol.2019.236588. doi: 10.3324/haematol.2019.236588. [Epub ahead of print] No abstract available.

2.

A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency.

Coignard-Biehler H, Mahlaoui N, Pilmis B, Barlogis V, Brosselin P, De Vergnes N, Debré M, Malphettes M, Frange P, Catherinot E, Pellier I, Durieu I, Perlat A, Royer B, Le Quellec A, Jeziorski E, Fischer A, Lortholary O; CEREDIH French PID study group, Aaron L, Adoue D, Aguilar C, Aladjidi N, Alcais A, Amoura Z, Arlet P, Armari-Alla C, Bader-Meunier B, Bayart S, Bertrand Y, Bienvenu B, Blanche S, Bodet D, Bonnotte B, Borie R, Boutard P, Briandet C, Brion JP, Brouard J, Cohen-Beaussant S, Costes L, Couderc LJ, Cougoul P, Courteille V, de Saint Basile G, Devoldere C, Deville A, Donadieu J, Dore E, Dulieu F, Edan C, Entz-Werle N, Fieschi C, Forestier A, Fouyssac F, Gajdos V, Galicier L, Gandemer V, Gardembas M, Gaud C, Guillerm G, Hachulla E, Hamidou M, Hermine O, Hoarau C, Humbert S, Jaccard A, Jacquot S, Jais JP, Jaussaud R, Jeandel PY, Kebaili K, Korganow AS, Lambotte O, Lanternier F, Larroche C, Lascaux AS, Le Moigne E, Le Moing V, Lebranchu Y, Lecuit M, Lefevre G, Lemal R, Te VLT, Marie-Cardine A, Silva NM, Masseau A, Massot C, Mazingue F, Merlin E, Michel G, Millot F, Monlibert B, Monpoux F, Moshous D, Mouthon L, Munzer M, Neven B, Nove-Josserand R, Oksenhendler E, Ouachée-Chardin M, Oudot C, Pagnier A, Pasquali JL, Pasquet M, Perel Y, Picard C, Piguet C, Plantaz D, Provot J, Quartier P, Rieux-Laucat F, Roblot P, Roger PM, Rohrlich PS, Rubie H, Salle V, Sarrot-Reynauld F, Servettaz A, Stephan JL, Schleinitz N, Suarez F, Swiader L, Taque S, Thomas C, Tournilhac O, Thumerelle C, Tron F, Vannier JP, Viallard JF.

J Clin Immunol. 2019 Oct;39(7):702-712. doi: 10.1007/s10875-019-00658-9. Epub 2019 Aug 10.

PMID:
31401750
3.

Lower respiratory tract amyloidosis: Presentation, survival and prognostic factors. A multicenter consecutive case series.

Rech JS, Arnulf B, de Margerie-Mellon C, Talbot A, Malphettes M, Vignon M, Royer B, Lavergne D, Kambouchner M, Meignin V, Bergeron A, Prevot G, Brillet PY, Martinod E, Bridoux F, Nunes H, Jaccard A, Valeyre D, Uzunhan Y.

Am J Hematol. 2019 Nov;94(11):1214-1226. doi: 10.1002/ajh.25608. Epub 2019 Aug 23.

PMID:
31396978
4.

Diagnostic score of cardiac involvement in AL amyloidosis.

Nicol M, Baudet M, Brun S, Harel S, Royer B, Vignon M, Lairez O, Lavergne D, Jaccard A, Attias D, Macron L, Gayat E, Cohen-Solal A, Arnulf B, Logeart D.

Eur Heart J Cardiovasc Imaging. 2019 Jul 10. pii: jez180. doi: 10.1093/ehjci/jez180. [Epub ahead of print]

PMID:
31292624
5.

Light chain lambda myeloma with fatal AL cardiac amyloidosis in a 21-year-old patient: A case report and review.

Camus V, Dubois S, Thiébaut PA, Lepretre S, Lenain P, Picquenot JM, Veresezan EL, François A, Penther D, Bauer F, Jaccard A, Jardin F.

Clin Case Rep. 2019 May 7;7(6):1171-1177. doi: 10.1002/ccr3.2165. eCollection 2019 Jun.

6.

Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma.

Perrot A, Lauwers-Cances V, Tournay E, Hulin C, Chretien ML, Royer B, Dib M, Decaux O, Jaccard A, Belhadj K, Brechignac S, Fontan J, Voillat L, Demarquette H, Collet P, Rodon P, Sohn C, Lifermann F, Orsini-Piocelle F, Richez V, Mohty M, Macro M, Minvielle S, Moreau P, Leleu X, Facon T, Attal M, Avet-Loiseau H, Corre J.

J Clin Oncol. 2019 Jul 1;37(19):1657-1665. doi: 10.1200/JCO.18.00776. Epub 2019 May 15.

7.

Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial.

Leleu X, Fouquet G, Richez V, Guidez S, Duhamel A, Machuron F, Karlin L, Kolb B, Tiab M, Araujo C, Meuleman N, Malfuson JV, Bourquard P, Lenain P, Roussel M, Jaccard A, Pétillon MO, Belhadj-Merzoug K, Lepeu G, Chrétien ML, Fontan J, Rodon P, Schmitt A, Offner F, Voillat L, Cereja S, Kuhnowski F, Rigaudeau S, Decaux O, Humbrecht-Kraut C, Frayfer J, Fitoussi O, Roos-Weil D, Eisenmann JC, Dorvaux V, Voog EG, Attal M, Moreau P, Avet-Loiseau H, Hulin C, Facon T.

Clin Cancer Res. 2019 Jul 15;25(14):4224-4230. doi: 10.1158/1078-0432.CCR-18-3642. Epub 2019 May 3.

PMID:
31053600
8.

Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disorders.

Javaugue V, Debiais-Delpech C, Nouvier M, Gand E, Chauvet S, Ecotiere L, Desport E, Goujon JM, Delwail V, Guidez S, Tomowiak C, Leleu X, Jaccard A, Rioux-Leclerc N, Vigneau C, Fermand JP, Touchard G, Thierry A, Bridoux F.

Kidney Int. 2019 Jul;96(1):94-103. doi: 10.1016/j.kint.2019.01.027. Epub 2019 Mar 15.

PMID:
30987838
9.

WITHDRAWN: [Treatment of AL amyloidosis].

Jaccard A, Bridoux F.

Nephrol Ther. 2019 Apr;15 Suppl 1:S115-S121. doi: 10.1016/j.nephro.2019.03.002. French.

PMID:
30981389
10.

Future trends in social inequalities in obesity in England, Wales and Scotland.

Keaver L, Pérez-Ferrer C, Jaccard A, Webber L.

J Public Health (Oxf). 2019 Mar 11. pii: fdz022. doi: 10.1093/pubmed/fdz022. [Epub ahead of print]

PMID:
30855666
11.

Screening and brief intervention for obesity in primary care: cost-effectiveness analysis in the BWeL trial.

Retat L, Pimpin L, Webber L, Jaccard A, Lewis A, Tearne S, Hood K, Christian-Brown A, Adab P, Begh R, Jolly K, Daley A, Farley A, Lycett D, Nickless A, Yu LM, Jebb S, Aveyard P.

Int J Obes (Lond). 2019 Oct;43(10):2066-2075. doi: 10.1038/s41366-018-0295-7. Epub 2019 Jan 31.

12.

Left ventricular assessment in patients with systemic light chain amyloidosis: a 3-dimensional speckle tracking transthoracic echocardiographic study.

Pradel S, Magne J, Jaccard A, Fadel BM, Boulogne C, Salemi VMC, Damy T, Aboyans V, Mohty D.

Int J Cardiovasc Imaging. 2019 May;35(5):845-854. doi: 10.1007/s10554-018-01524-2. Epub 2019 Jan 8.

PMID:
30623354
13.

Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study.

Joly F, Cohen C, Javaugue V, Bender S, Belmouaz M, Arnulf B, Knebelmann B, Nouvier M, Audard V, Provot F, Gnemmi V, Nochy D, Goujon JM, Jaccard A, Touchard G, Fermand JP, Sirac C, Bridoux F.

Blood. 2019 Feb 7;133(6):576-587. doi: 10.1182/blood-2018-09-872028. Epub 2018 Dec 21.

PMID:
30578255
14.

Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D'Agati VD, Dispenzieri A, Fervenza FC, Fermand JP, Gibbs S, Gillmore JD, Herrera GA, Jaccard A, Jevremovic D, Kastritis E, Kukreti V, Kyle RA, Lachmann HJ, Larsen CP, Ludwig H, Markowitz GS, Merlini G, Mollee P, Picken MM, Rajkumar VS, Royal V, Sanders PW, Sethi S, Venner CP, Voorhees PM, Wechalekar AD, Weiss BM, Nasr SH.

Nat Rev Nephrol. 2019 Feb;15(2):121. doi: 10.1038/s41581-018-0102-7.

PMID:
30568288
15.

Thoracic spine dislocation in Gorham-Stout Syndrome: Case report and literature review.

Jaccard A, Macedo C, Castro G, Guiroy A.

Surg Neurol Int. 2018 Nov 1;9:223. doi: 10.4103/sni.sni_311_18. eCollection 2018.

16.

Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation.

Avenell A, Robertson C, Skea Z, Jacobsen E, Boyers D, Cooper D, Aceves-Martins M, Retat L, Fraser C, Aveyard P, Stewart F, MacLennan G, Webber L, Corbould E, Xu B, Jaccard A, Boyle B, Duncan E, Shimonovich M, Bruin M.

Health Technol Assess. 2018 Nov;22(68):1-246. doi: 10.3310/hta22680.

17.

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D'Agati VD, Dispenzieri A, Fervenza FC, Fermand JP, Gibbs S, Gillmore JD, Herrera GA, Jaccard A, Jevremovic D, Kastritis E, Kukreti V, Kyle RA, Lachmann HJ, Larsen CP, Ludwig H, Markowitz GS, Merlini G, Mollee P, Picken MM, Rajkumar VS, Royal V, Sanders PW, Sethi S, Venner CP, Voorhees PM, Wechalekar AD, Weiss BM, Nasr SH.

Nat Rev Nephrol. 2019 Jan;15(1):45-59. doi: 10.1038/s41581-018-0077-4. Erratum in: Nat Rev Nephrol. 2019 Feb;15(2):121.

PMID:
30510265
18.

Forecasting Future Trends in Obesity across Europe: The Value of Improving Surveillance.

Pineda E, Sanchez-Romero LM, Brown M, Jaccard A, Jewell J, Galea G, Webber L, Breda J.

Obes Facts. 2018;11(5):360-371. doi: 10.1159/000492115. Epub 2018 Oct 12.

19.

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma.

Garderet L, Kuhnowski F, Berge B, Roussel M, Escoffre-Barbe M, Lafon I, Facon T, Leleu X, Karlin L, Perrot A, Moreau P, Marit G, Stoppa AM, Royer B, Chaleteix C, Tiab M, Araujo C, Lenain P, Macro M, Voog E, Benboubker L, Allangba O, Jourdan E, Orsini-Piocelle F, Brechignac S, Eveillard JR, Belhadj K, Wetterwald M, Pegourie B, Jaccard A, Eisenmann JC, Glaisner S, Mohty M, Hulin C, Loiseau HA, Mathiot C, Attal M.

Blood. 2018 Dec 13;132(24):2555-2563. doi: 10.1182/blood-2018-07-863829. Epub 2018 Oct 3.

PMID:
30282798
20.

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.

Perrot A, Lauwers-Cances V, Corre J, Robillard N, Hulin C, Chretien ML, Dejoie T, Maheo S, Stoppa AM, Pegourie B, Karlin L, Garderet L, Arnulf B, Doyen C, Meuleman N, Royer B, Eveillard JR, Benboubker L, Dib M, Decaux O, Jaccard A, Belhadj K, Brechignac S, Kolb B, Fohrer C, Mohty M, Macro M, Richardson PG, Carlton V, Moorhead M, Willis T, Faham M, Anderson KC, Harousseau JL, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H, Munshi N.

Blood. 2018 Dec 6;132(23):2456-2464. doi: 10.1182/blood-2018-06-858613. Epub 2018 Sep 24.

21.

Comparison of echocardiographic parameters in Fabry cardiomyopathy and light-chain cardiac amyloidosis.

Marek J, Palecek T, Magne J, Lavergne D, Boulogne C, Fadel BM, Jaccard A, Linhart A, Mohty D.

Echocardiography. 2018 Nov;35(11):1755-1763. doi: 10.1111/echo.14144. Epub 2018 Sep 24.

PMID:
30247786
22.

Morbid obesity in the UK: A modelling projection study to 2035.

Keaver L, Xu B, Jaccard A, Webber L.

Scand J Public Health. 2018 Aug 30:1403494818794814. doi: 10.1177/1403494818794814. [Epub ahead of print]

PMID:
30160640
23.

[Aneurysm of the portal venous system: A rare and unknown pathology].

Chaubard S, Lacroix P, Kennel C, Jaccard A.

Rev Med Interne. 2018 Dec;39(12):946-949. doi: 10.1016/j.revmed.2018.07.007. Epub 2018 Aug 23. French.

PMID:
30146175
24.

Author's reply.

Mohty D, Petitalot V, Magne J, Fadel BM, Boulogne C, Rouabhia D, Hamel CE, Lavergne D, Damy T, Aboyans V, Jaccard A.

J Cardiol. 2018 Oct;72(4):368. doi: 10.1016/j.jjcc.2018.02.004. No abstract available.

25.

Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p.

Wong SW, Hegenbart U, Palladini G, Shah GL, Landau HJ, Warner M, Toskic D, Jaccard A, Hansen T, Bladé J, Cibeira MT, Kastritis E, Dispenzieri A, Wechalekar A, Varga C, Schönland SO, Comenzo RL.

Clin Lymphoma Myeloma Leuk. 2018 Nov;18(11):e493-e499. doi: 10.1016/j.clml.2018.07.292. Epub 2018 Jul 25.

26.

Comprehensive molecular characterization of a heavy chain deposition disease case.

Bender S, Ayala MV, Javaugue V, Bonaud A, Cogné M, Touchard G, Jaccard A, Bridoux F, Sirac C.

Haematologica. 2018 Nov;103(11):e557-e560. doi: 10.3324/haematol.2018.196113. Epub 2018 Jul 19. No abstract available.

27.

Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications.

Fermand JP, Bridoux F, Dispenzieri A, Jaccard A, Kyle RA, Leung N, Merlini G.

Blood. 2018 Oct 4;132(14):1478-1485. doi: 10.1182/blood-2018-04-839480. Epub 2018 Jul 16. Review.

PMID:
30012636
28.

Pathology of Nerve Biopsy and Diagnostic Yield of PCR-Based Clonality Testing in Neurolymphomatosis.

Duchesne M, Roussellet O, Maisonobe T, Gachard N, Rizzo D, Armand M, Viala K, Richard L, Delage-Corre M, Jaccard A, Corcia P, Vallat JM, Magy L.

J Neuropathol Exp Neurol. 2018 Sep 1;77(9):769-781. doi: 10.1093/jnen/nly055.

PMID:
30011033
29.

Estimating the costs of air pollution to the National Health Service and social care: An assessment and forecast up to 2035.

Pimpin L, Retat L, Fecht D, de Preux L, Sassi F, Gulliver J, Belloni A, Ferguson B, Corbould E, Jaccard A, Webber L.

PLoS Med. 2018 Jul 10;15(7):e1002602. doi: 10.1371/journal.pmed.1002602. eCollection 2018 Jul.

30.

Campylobacter infection in adult patients with primary antibody deficiency.

Dion J, Malphettes M, Bénéjat L, Mégraud F, Wargnier A, Boutboul D, Galicier L, Le Moing V, Giraud P, Jaccard A, Nove-Josserand R, Fieschi C, Oksenhendler E, Gérard L; DEFI study group.

J Allergy Clin Immunol Pract. 2019 Mar;7(3):1038-1041.e4. doi: 10.1016/j.jaip.2018.06.014. Epub 2018 Jul 6. No abstract available.

PMID:
29981862
31.

Normal serum protein electrophoresis and mutated IGHV genes detect very slowly evolving chronic lymphocytic leukemia patients.

Chauzeix J, Laforêt MP, Deveza M, Crowther L, Marcellaud E, Derouault P, Lia AS, Boyer F, Bargues N, Olombel G, Jaccard A, Feuillard J, Gachard N, Rizzo D.

Cancer Med. 2018 Jun;7(6):2621-2628. doi: 10.1002/cam4.1510. Epub 2018 May 9.

32.

Inequalities in smoking and obesity in Europe predicted to 2050: Findings from the EConDA project.

Pérez-Ferrer C, Jaccard A, Knuchel-Takano A, Retat L, Brown M, Kriaucioniene V, Webber L.

Scand J Public Health. 2018 Jul;46(5):530-540. doi: 10.1177/1403494818761416. Epub 2018 Mar 8.

PMID:
29516788
33.

Modelling the implications of reducing smoking prevalence: the benefits of increasing the UK tobacco duty escalator to public health and economic outcomes.

Knuchel-Takano A, Hunt D, Jaccard A, Bhimjiyani A, Brown M, Retat L, Brown K, Hinde S, Selvarajah C, Bauld L, Webber L.

Tob Control. 2018 Oct;27(e2):e124-e129. doi: 10.1136/tobaccocontrol-2017-053860. Epub 2017 Dec 6.

34.

Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial.

Bridoux F, Carron PL, Pegourie B, Alamartine E, Augeul-Meunier K, Karras A, Joly B, Peraldi MN, Arnulf B, Vigneau C, Lamy T, Wynckel A, Kolb B, Royer B, Rabot N, Benboubker L, Combe C, Jaccard A, Moulin B, Knebelmann B, Chevret S, Fermand JP; MYRE Study Group.

JAMA. 2017 Dec 5;318(21):2099-2110. doi: 10.1001/jama.2017.17924.

35.

Identification of differences in health impact modelling of salt reduction.

Hendriksen MAH, Geleijnse JM, van Raaij JMA, Cappuccio FP, Cobiac LC, Scarborough P, Nusselder WJ, Jaccard A, Boshuizen HC.

PLoS One. 2017 Nov 28;12(11):e0186760. doi: 10.1371/journal.pone.0186760. eCollection 2017.

36.

POEMS Syndrome: Therapeutic Options.

Jaccard A.

Hematol Oncol Clin North Am. 2018 Feb;32(1):141-151. doi: 10.1016/j.hoc.2017.09.011. Review.

PMID:
29157615
37.

Left atrial function in patients with light chain amyloidosis: A transthoracic 3D speckle tracking imaging study.

Mohty D, Petitalot V, Magne J, Fadel BM, Boulogne C, Rouabhia D, ElHamel C, Lavergne D, Damy T, Aboyans V, Jaccard A.

J Cardiol. 2018 Apr;71(4):419-427. doi: 10.1016/j.jjcc.2017.10.007. Epub 2017 Nov 16.

38.

Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma.

Kwong YL, Kim SJ, Tse E, Oh SY, Kwak JY, Eom HS, Do YR, Mun YC, Lee SR, Shin HJ, Suh C, Chuang SS, Lee YS, Lim ST, Izutsu K, Suzuki R, Relander T, d'Amore F, Schmitz N, Jaccard A, Kim WS.

Ann Oncol. 2018 Jan 1;29(1):256-263. doi: 10.1093/annonc/mdx684.

PMID:
29077846
39.

Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis.

Abbaci A, Talbot H, Saada S, Gachard N, Abraham J, Jaccard A, Bordessoule D, Fauchais AL, Naves T, Jauberteau MO.

Oncogene. 2018 Feb 8;37(6):756-767. doi: 10.1038/onc.2017.365. Epub 2017 Oct 23.

40.

A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis.

Sanchorawala V, Palladini G, Kukreti V, Zonder JA, Cohen AD, Seldin DC, Dispenzieri A, Jaccard A, Schönland SO, Berg D, Yang H, Gupta N, Hui AM, Comenzo RL, Merlini G.

Blood. 2017 Aug 3;130(5):597-605. doi: 10.1182/blood-2017-03-771220. Epub 2017 May 26.

41.

Modelling the implications of reducing smoking prevalence: the public health and economic benefits of achieving a 'tobacco-free' UK.

Hunt D, Knuchel-Takano A, Jaccard A, Bhimjiyani A, Retat L, Selvarajah C, Brown K, Webber LL, Brown M.

Tob Control. 2018 Mar;27(2):129-135. doi: 10.1136/tobaccocontrol-2016-053507. Epub 2017 May 11.

PMID:
28495977
42.

Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial.

Ahern AL, Wheeler GM, Aveyard P, Boyland EJ, Halford JCG, Mander AP, Woolston J, Thomson AM, Tsiountsioura M, Cole D, Mead BR, Irvine L, Turner D, Suhrcke M, Pimpin L, Retat L, Jaccard A, Webber L, Cohn SR, Jebb SA.

Lancet. 2017 Jun 3;389(10085):2214-2225. doi: 10.1016/S0140-6736(17)30647-5. Epub 2017 May 3. Erratum in: Lancet. 2017 Jun 3;389(10085):2192.

43.

[Classification and therapeutic management of monoclonal gammopathies of renal significance].

Javaugue V, Bouteau I, Sirac C, Quellard N, Diolez J, Colombo A, Desport E, Ecotière L, Goujon JM, Fermand JP, Touchard G, Jaccard A, Bridoux F.

Rev Med Interne. 2018 Mar;39(3):161-170. doi: 10.1016/j.revmed.2017.03.012. Epub 2017 Apr 27. Review. French.

PMID:
28457684
44.

A major turning point in NK/T-cell lymphoma?

Jaccard A, Hermine O.

Blood. 2017 Apr 27;129(17):2342-2343. doi: 10.1182/blood-2017-03-769075. No abstract available.

PMID:
28450574
45.

Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays.

Palladini G, Jaccard A, Milani P, Lavergne D, Foli A, Bender S, Lavatelli F, Bosoni T, Valentini V, Pirolini L, Ferraro G, Basset M, Russo F, Nuvolone M, Albertini R, Cogne M, Merlini G.

Clin Chem Lab Med. 2017 Oct 26;55(11):1734-1743. doi: 10.1515/cclm-2016-1024.

PMID:
28343171
46.

Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosis.

Le Bras F, Molinier-Frenkel V, Guellich A, Dupuis J, Belhadj K, Guendouz S, Ayad K, Colombat M, Benhaiem N, Tissot CM, Hulin A, Jaccard A, Damy T.

Eur J Cancer. 2017 May;76:183-187. doi: 10.1016/j.ejca.2017.02.004. Epub 2017 Mar 20.

PMID:
28334621
47.

[Monoclonal gammopathy of renal significance].

Javaugue V, Debiaisdelpech C, Desport É, Écotière L, Fermand JP, Touchard G, Jaccard A, Bridoux F.

Rev Prat. 2017 Jan;67(1):71-75. French.

PMID:
30512440
48.

Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis.

Mohty D, Pradel S, Magne J, Fadel B, Boulogne C, Petitalot V, Raboukhi S, Darodes N, Damy T, Aboyans V, Jaccard A.

Clin Res Cardiol. 2017 May;106(5):331-340. doi: 10.1007/s00392-016-1058-x. Epub 2016 Dec 8.

PMID:
27933393
49.

Cost savings of home bortezomib injection in patients with multiple myeloma treated by a combination care in Outpatient Hospital and Hospital care at Home.

Touati M, Lamarsalle L, Moreau S, Vergnenègre F, Lefort S, Brillat C, Jeannet L, Lagarde A, Daulange A, Jaccard A, Vergnenègre A, Bordessoule D.

Support Care Cancer. 2016 Dec;24(12):5007-5014. Epub 2016 Aug 15.

50.

Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.

Bridoux F, Javaugue V, Bender S, Leroy F, Aucouturier P, Debiais-Delpech C, Goujon JM, Quellard N, Bonaud A, Clavel M, Trouillas P, Di Meo F, Gombert JM, Fermand JP, Jaccard A, Cogné M, Touchard G, Sirac C.

Kidney Int. 2017 Feb;91(2):423-434. doi: 10.1016/j.kint.2016.09.004. Epub 2016 Oct 20.

PMID:
27773425

Supplemental Content

Loading ...
Support Center